Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-025135
Filing Date
2025-05-13
Accepted
2025-05-13 16:41:15
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20250331.htm   iXBRL 10-Q 1333723
2 EX-31.1 lyel-20250331x10qxexx311.htm EX-31.1 10647
3 EX-31.2 lyel-20250331x10qxexx312.htm EX-31.2 10617
4 EX-32.1 lyel-20250331x10qxexx321.htm EX-32.1 7491
10 lyel-20250331_g1.jpg GRAPHIC 680016
11 lyel-20250331_g2.jpg GRAPHIC 74168
12 lyel-20250331_g3.jpg GRAPHIC 16424
13 lyel-20250331_g4.jpg GRAPHIC 926546
14 lyel-20250331_g5.jpg GRAPHIC 79373
15 lyel-20250331_g6.jpg GRAPHIC 221356
16 lyel-20250331_g7.jpg GRAPHIC 215761
  Complete submission text file 0001628280-25-025135.txt   12180846

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20250331.xsd EX-101.SCH 46509
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20250331_cal.xml EX-101.CAL 58030
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20250331_def.xml EX-101.DEF 248682
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20250331_lab.xml EX-101.LAB 620030
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20250331_pre.xml EX-101.PRE 441261
80 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20250331_htm.xml XML 859498
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 25940862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)